{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:01:08Z","timestamp":1761843668603},"reference-count":10,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T00:00:00Z","timestamp":1179360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1111\/j.1468-3083.2007.02197.x","type":"journal-article","created":{"date-parts":[[2007,5,18]],"date-time":"2007-05-18T20:41:26Z","timestamp":1179520886000},"page":"1294-1296","source":"Crossref","is-referenced-by-count":29,"title":["Adalimumab\u2010induced pityriasis rosea"],"prefix":"10.1111","volume":"21","author":[{"given":"SM","family":"Rajpara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AD","family":"Ormerod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Gallaway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,9,14]]},"reference":[{"key":"e_1_2_2_2_2","unstructured":"Abbott Laboratories Ltd.Adalimumab (Humira); Summary of Product Characteristics 2005."},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh464"},{"key":"e_1_2_2_4_2","unstructured":"GoodfieldMJD JonesSK VealeDJ.The \u2018connective tissue diseases\u2019. In:BurnsT BreathnachS CoxN GriggithsC eds.Textbook of Dermatology Vol. 2 7th edn.Blackwell Science Oxford 2004:56.138\u201356.140."},{"key":"e_1_2_2_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar1724"},{"key":"e_1_2_2_6_2","first-page":"6","volume":"1010","year":"2004","journal-title":"Reactions Weekly"},{"key":"e_1_2_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20155"},{"key":"e_1_2_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2005.02635.x"},{"key":"e_1_2_2_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23719.x"},{"key":"e_1_2_2_10_2","first-page":"481","article-title":"Th2\u2010mediated atopic disease protection in Th1\u2010mediated rheumatoid arthritis","volume":"21","author":"Hartung AD","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_2_11_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120568"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2007.02197.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2007.02197.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T17:09:39Z","timestamp":1696957779000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2007.02197.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,14]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1468-3083.2007.02197.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02197.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,14]]}}}